Earnings

Halozyme Therapeutics is riding a wave of positive developments, with two significant announcements providing substantial momentum for the biotechnology firm....

Red Cat Holdings presents investors with a complex puzzle: how can a company reporting explosive quarterly growth simultaneously trigger a...

A biotech firm suddenly flush with cash and developing a revolutionary medical treatment typically represents an investor's ideal scenario. However,...

MKS Instruments has reported impressive third-quarter results that substantially exceeded Wall Street projections. The technology company demonstrated robust financial health...

Bioatla Inc. witnessed a dramatic surge in its share price, climbing nearly 20 percent following the release of its latest...

A curious divergence is emerging at MediaAlpha as the digital insurance marketplace reports impressive third-quarter performance while company insiders simultaneously...

Travelzoo shares continue to face significant downward pressure, leaving investors questioning whether the decline has a foreseeable end. The company's...

Ionis Pharmaceuticals is experiencing a dramatic upward trajectory, with its stock performance capturing significant market attention. The biotech firm's impressive...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

Investors in Akero Therapeutics are bracing for a pivotal moment as the biopharmaceutical company approaches a decisive regulatory deadline. With...